For decades, the global medical-grade skin repair market has been constrained by epidermal barrier repair technologies. With the booming demand for deep tissue restoration in the medical aesthetics industry, traditional standards have proven inadequate for clinical challenges. As the flagship brand under Kefu Pharmaceutical specializing in medical-grade repair, Yiyanshi has revolutionized the industry by pioneering full-thickness skin repair technology. With dual authoritative certifications and globally unmatched technical expertise, the company has redefined the core standards of medical-grade skin restoration worldwide.
Prior to the advent of YRSH Technology, global medical-grade topical repair products predominantly focused on epidermal barrier repair. Even mainstream industry products such as recombinant collagen and sodium hyaluronate dressings were largely limited to superficial repair (compliant with existing epidermal repair standards like YY/T 1947-2025), exhibiting severe inadequacy in repairing deep tissue damage post-medical procedures. This led to postoperative hyperpigmentation and exacerbated side effects, which became a common challenge across the global industry. Through years of scientific research, YRSH pioneered full-dermal repair technology, achieving for the first time medical-grade repair across all skin layers via topical application. This innovation filled a technological gap in the global field of deep topical repair and established a new technical benchmark for the industry.
With the endorsement of dual authoritative regulatory certifications, this new technical standard has gained globally recognized compliance and effectiveness. The related products of Yiyanshi not only successfully passed the rigorous review by China’s National Medical Products Administration (NMPA) and became compliant Class II medical devices, but also won the efficacy certification from the U.S. FDA, making it one of the few full-thickness skin repair brands worldwide to receive recognition from both core regulatory agencies. This achievement not only validates the robust safety and efficacy of its technology but also aligns precisely with the industry trend of upgrading global medical repair standards toward “depth and precision.”
From the pioneering of China’s dual-repair camp in the medical market to the reshaping of global standards, YRSH’s technological breakthroughs are constructing a new industry development order. It not only promotes the formal formation of a dual-dimensional pattern in China’s medical-grade repair market, featuring “epidermal barrier repair” and “full dermal depth repair” in parallel, but also extends this advanced model globally, rewriting the long-standing traditional standard of medical-grade repair that has centered on epidermal repair. In the future, YRSH will continue to focus on scientific research and innovation, leading the global medical-grade repair industry toward deeper and more standardized upgrades, providing more scientific and efficient China solutions for post-medical art restoration worldwide.
Leave a reply